In 1975, a Kodak engineer named Steve Sasson built the world's first digital camera in a company lab. Eight pounds. Black-and-white. 0.01 megapixels. Kodak saw the future — and filed every relevant patent. Then it did what most companies do when a new technology threatens a profitable present: it shelved the invention. Digital stayed a side project, priced and positioned so it would not disturb the film business that generated 90% of Kodak's revenue. Thirty-seven years later, the company that once held 90% of the US film market filed for bankruptcy. Its failure was not a failure of vision. It was a failure of time horizon.
Eastman Kodak is the archetype of a pattern that repeats in boardrooms every single year. Companies without a strategic planning discipline default to the only planning cycle they know: the 12-month operational budget. In that cycle, the goal is simple — maximize revenue while minimizing cost. And the first thing to go is always the work whose payoff lies beyond the current fiscal year. Innovation. R&D. Strategic initiatives. Market development. These are not line items you can defend with a 12-month ROI projection. They look like costs on the budget sheet and liabilities on the executive dashboard. And every year, they are the first to be cut.
The problem is not that leaders are short-sighted. It is that the system was built to be short-sighted. Executive KPIs, compensation cycles, analyst expectations, and quarterly reporting rhythms are all calibrated to a 12-month horizon. When your bonus depends on this year's earnings, investing in next decade's growth is not just irrational — it is personally costly. The system does not punish short-term thinking. It rewards it.
A) What Is the Problem
Companies that have never built a strategic planning muscle default to treating the annual budget as their strategy. The two are not the same. A budget allocates resources to existing operations. A strategy decides what new operations to create, what future markets to enter, and what capabilities to build that do not exist today. When the budget is the only planning horizon, the future gets whatever is left over after the present is funded — and that is usually nothing.
This pattern is neither rare nor subtle. A 2025 survey by Corporate Board Member and the Long-Term Stock Exchange found that 61% of American CEOs and board members cite economic uncertainty as their top short-term challenge, and that this pressure is directly causing companies to pull back on long-term investments. Among the strategies most at risk: capital investment (33%), innovation and R&D (25%), and market expansion (24%). One in four companies is quietly starving the very functions that would build their future — not because they do not know better, but because the annual planning cycle gives them no cover to do otherwise.
The consequences are measurable. McKinsey's Corporate Horizon Index, spanning 615 large US publicly listed companies from 2001 to 2015, found that long-term-oriented companies (those that consistently invested in R&D, maintained stable earnings quality, and avoided accounting maneuvers to meet short-term targets) dramatically outperformed their short-term-focused peers. Their revenue grew 47% more. Their earnings grew 36% more. Their economic profit grew 81% more. And during the 2008 financial crisis — when pressure to cut was greatest — long-term companies continued increasing R&D investment at an annualized rate of 8.5%, while short-term companies cut spending to 3.7%. The gap compounded into a structural advantage that persists to this day.
Yet the pressure to cut is escalating, not receding. In 2022, a change in US tax law forced companies to amortize R&D expenses over five years instead of deducting them immediately. Stanford researchers found that among the most research-intensive firms, this single rule change triggered a $12 billion drop in R&D investment — an 11% decline. The tax change was never supposed to take effect; Congress had intended to repeal it. But it did take effect, and the market response was immediate and mechanical: when R&D became more expensive on the annual income statement, companies cut it. The signal from the 12-month planning cycle was unambiguous.
This is not a US phenomenon. FCLTGlobal, a nonprofit that researches long-term investment behavior, found that worldwide R&D spending doubled between 2009 and 2018, from $374 billion to $778 billion. But the productivity of that spending fell sharply, with returns on pharmaceutical R&D dropping to just 1.9% by 2018. The reason, their interviews with industry experts revealed, is that corporate management teams systematically cut long-horizon projects first when under pressure, leaving unbalanced innovation portfolios that favor safe, incremental bets over transformative ones. The result is more spending on less ambitious work — the worst of both worlds.
B) Why This Is a Problem to You
The 12-month planning cycle does not merely reduce your innovation output. It systematically dismantles your ability to respond to three forces that no annual budget can contain.
1. The Economic Cycle Will Hit — And You Will Have No Buffer
Every business cycle eventually turns. When it does, companies that spent the expansion years cutting strategy, R&D, and market development have no new products, no new markets, no new capabilities to fall back on. Their only option is to cut deeper — laying off the people who would have built the next growth engine, shrinking the very functions they need to recover. McKinsey's data shows that long-term companies actually increased R&D investment during the 2008 crisis while short-term companies cut. When the recovery came, the long-term companies had products ready to launch. The short-term companies had nothing but smaller budgets and fewer options.
2. Competition Will Intensify — And You Will Have No Response
When your competitor has spent three years building a technology platform, a distribution network, or a customer ecosystem, you cannot replicate it in a single budget cycle. The gap that opens during those years is structural, not tactical. Intel provides a sobering case. Its stock fell 60% in 2024, and the company posted the largest loss in its 56-year history. Six former executives told Yahoo Finance that previous CEOs Brian Krzanich and Bob Swan "prioritized short-term thinking over long-term technology strategies." Innovative efforts were killed if they did not immediately contribute to revenue. Meanwhile, TSMC and AMD invested through the cycle. The result: Intel now hemorrhages market share in the very market it created, and analysts suggest the company should spin off or divest the manufacturing division it spent decades building. The gap was not created by a single bad quarter. It was created by a decade of 12-month decisions.
3. A New Entrant With Technology Edge Will Disrupt You — And You Will Be a Sitting Duck
Kodak did not miss digital photography. It invented it — and then chose film. Nokia did not miss the smartphone. It dominated mobile phones with a 40% global market share — and then chose Symbian over the ecosystem shift. Blockbuster did not miss streaming. It had 9,000 stores, 80,000 employees — and chose the store-based model over the future. In every case, the leaders were not blind. They were trapped by their own planning horizon. The question they asked was not "what should we become?" but "how do we protect what we already have?" That question is the natural output of a 12-month planning system. And it is the question that loses markets.
The academic evidence is stark. A study published in the Journal of Financial and Quantitative Analysis found that hedge fund activism — one of the most aggressive forms of short-term pressure — leads to a 14% to 20% decline in scientific publications at targeted firms, with cuts concentrated in high-impact journals. The same firms redirect R&D toward incremental "me-too" products and away from novel compounds. In other words, the pressure to deliver short-term returns does not just reduce innovation volume — it changes the type of innovation a company pursues, shifting it from foundational research to the safest possible bets while leaving the truly transformative work unfunded.
CEOs themselves know they are underprepared. The same Corporate Board Member survey found that when asked to rate their company's ability to compete over the next 3 to 5 years, CEOs and directors gave themselves an average of 6.9 out of 10 — not a failing grade, but not a confident one either, given what is at stake.
C) Here Is What You Can Do About It
1. Decouple Strategic Investment From the Operational Budget
The single most important structural change a board can make is to fund strategic initiatives on a separate P&L. Innovation, R&D, and market development should not compete for the same pool of resources as headcount, office space, and maintenance. They are not the same category of expense. Treat them as separate investment vehicles with their own return horizon — 3 to 5 years, not 12 months. This is not accounting cosmetics. It is a recognition that a dollar spent on building a new capability is fundamentally different from a dollar spent on operating an existing one. They answer to different logic, different timelines, and different governance.
FCLTGlobal's research supports this structurally: companies that reinvest a greater portion of earnings internally, including into R&D projects, outperform their peers by 9% per year on average. But this only works when the investment horizon matches the investment type. Funding a 5-year market development program on a 12-month budget cycle is like planting an orchard and expecting to harvest in the first spring.
2. Redesign Executive KPIs To Measure Long-Term Value Creation
McKinsey's research is unambiguous: compensation structures tied to annual performance create incentives for managers to defer value-adding investments. A study found that nearly 40% of CFOs would give discounts to customers to make purchases this quarter rather than the next — actively destroying value to meet a 90-day target. The fix is not to eliminate quarterly reporting (that carries its own costs in liquidity and transparency, as McKinsey notes). The fix is to change what executives are measured against.
Leading practice among long-term-oriented companies includes: weighting 20-30% of executive compensation against 3-year strategic milestones rather than annual financial targets; embedding R&D efficiency metrics alongside revenue targets; and requiring board-level review of innovation pipeline health as a standing agenda item — not an annual offsite topic that gets deprioritized when budgets are tight. Only 3 out of 24 institutional investors surveyed by McKinsey believed it was important for companies to consistently meet consensus estimates. The rest said they were satisfied with a company sometimes beating and sometimes missing, as long as it was making progress toward long-term goals. The pressure to hit quarterly numbers is, in part, a self-inflicted wound.
3. Institute a Strategic Planning Cadence Separate From Budgeting
Most companies run their strategy process as an input to the annual budget. This is backwards. Strategy should define the direction; the budget should fund the execution. When the budget drives strategy, the company optimizes for what it already knows how to measure. And what it already knows how to measure is last year's performance.
A separate strategic planning cadence — quarterly strategy reviews rather than annual, dedicated strategy teams that report to the board rather than the CFO, and a formal "innovation portfolio" with explicit allocation across short-, medium-, and long-horizon projects — creates the organizational space for the future to compete with the present. McKinsey's research on dynamic resource reallocation found that companies that actively shift capital and talent toward high-value opportunities earn significantly higher shareholder returns than those that let resources stagnate. Yet 45% of executives surveyed said their companies simply add to existing budgets year after year rather than reallocating to specific strategic priorities. The inertia is structural — but it can be broken with the right governance.
4. Recognize the J-Curve — And Build the Governance To Withstand It
Strategic investment follows a J-curve, not a hockey stick. In the first 12 to 24 months, costs are visible, measurable, and booked against the current year's P&L. Returns do not appear until year three or four — and when they do, they are rarely attributable to the original investment in a way that fits an annual budget review. This asymmetry between visible costs and invisible returns is the single biggest reason strategic initiatives get defunded before they bear fruit.
The solution is board-level governance that explicitly budgets for this shape: a strategic investment reserve funded over a 3-year rolling cycle, with milestone-based reviews rather than annual renewal battles. This is not charity. It is the same logic that venture capital firms apply to their portfolio companies — and the same logic that enabled long-term companies in McKinsey's study to create 12,000 more jobs per firm and generate the equivalent of $1 trillion in additional GDP if extrapolated across all US publicly listed companies. The J-curve is not a bug. It is the structure of any investment that outruns the current fiscal year.
The Bottom Line
Your company's 12-month budget cycle is not a strategy. It is a default — and defaults favor the present over the future every single time.
The evidence is consistent across industries, geographies, and decades. Kodak chose film and lost everything. Intel chose quarterly earnings and lost its technological leadership. Nokia chose Symbian and lost the smartphone market. McKinsey's data shows that long-term companies outperform short-term companies by nearly every measure — revenue growth, earnings, economic profit, R&D investment, job creation — yet the pressure to think short-term has been rising, not falling, over the last decade.
The board's job is not to approve next year's budget. It is to ensure that the company exists in the year after that. That requires a planning horizon that starts at 3 to 5 years and works backward — funding innovation, strategy, and market development not as discretionary costs but as non-negotiable investments in corporate survival. The 12-month trap is comfortable because it is familiar. But the companies that escape it are the ones that still exist in a decade.
References
- Anthony, S. (2016, July 15). Kodak's downfall wasn't about technology. Harvard Business Review.
- Babcock, A., Koller, T., & Potter, V. (2019). Corporate long-term behaviors: How CEOs and boards drive sustained value creation. FCLTGlobal & McKinsey & Company.
- Barton, D., & Wiseman, M. (2014). Focusing capital on the long term. Harvard Business Review.
- Corporate Board Member & Long-Term Stock Exchange. (2025). Short-term pressures putting long-term growth in jeopardy: CBM survey finds. Corporate Board Member Research.
- Cowx, M., Lester, R., & Nessa, M. (2024). The impact of R&D amortization on corporate innovation. Stanford Institute for Economic Policy Research (SIEPR).
- Ferracuti, E., et al. (2025). Hedge fund activism and the retreat from corporate science. Available at SSRN.
- FCLTGlobal. (2020). Funding the future: Investing in long-horizon innovation. FCLTGlobal Research Report.
- Koller, T., & Lovallo, D. (2024). The case against corporate short-termism. McKinsey & Company / Milken Institute Review.
- Koller, T., Lovallo, D., & Viguerie, P. (2001-2015). Corporate Horizon Index: Where companies with a long-term view outperform their peers. McKinsey & Company.
- Tong, J. Y., & Zhang, F. (2024). Do capital markets punish managerial myopia? Evidence from myopic research and development cuts. Journal of Financial and Quantitative Analysis, 59(2), 596-625.
- Yahoo Finance. (2025). How innovation died at Intel: America's only leading-edge chip manufacturer faces an uncertain future. Yahoo Finance.